These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1526512

  • 1. Diagnostic and prognostic significance of the mitotic index in endometrial adenocarcinoma.
    Pirog EC, Czerwinski W.
    Gynecol Oncol; 1992 Sep; 46(3):337-40. PubMed ID: 1526512
    [Abstract] [Full Text] [Related]

  • 2. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
    Kyushima N, Watanabe J, Hata H, Jobo T, Kameya T, Kuramoto H.
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
    [Abstract] [Full Text] [Related]

  • 3. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
    Blandamura S, Alessandrini L, Saccardi C, Giacomelli L, Fabris A, Borghero A, Litta P.
    Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
    Norimatsu Y, Shimizu K, Kobayashi TK, Moriya T, Tsukayama C, Miyake Y, Ohno E.
    Cancer; 2006 Apr 25; 108(2):77-85. PubMed ID: 16463402
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic histologic criteria of atypical adenomatous hyperplasia and well differentiated adenocarcinoma of the endometrium.
    Liapis A, Pafitis A, Hassiakos D, Chirakis M, Zourlas PA.
    Eur J Gynaecol Oncol; 1994 Apr 25; 15(6):464-8. PubMed ID: 7875162
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, Mychalczak BR, McKee B, Hoskins WJ, Barakat RR.
    Cancer; 2002 Jul 15; 95(2):316-21. PubMed ID: 12124832
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
    Sivridis E, Giatromanolaki A, Koukourakis MI, Georgiou L, Anastasiadis P.
    Histopathology; 2002 Jan 15; 40(1):92-100. PubMed ID: 11903603
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia.
    Shutter J, Wright TC.
    Int J Gynecol Pathol; 2005 Oct 15; 24(4):313-8. PubMed ID: 16175074
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
    Geels YP, Pijnenborg JM, van den Berg-van Erp SH, Bulten J, Visscher DW, Dowdy SC, Massuger LF.
    Obstet Gynecol; 2012 Nov 15; 120(5):1124-31. PubMed ID: 23090531
    [Abstract] [Full Text] [Related]

  • 18. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG.
    Gynecol Oncol; 2009 Jun 15; 113(3):316-23. PubMed ID: 19345400
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.